Need professional-grade analysis? Visit stockanalysis.com
$31.34M
N/A
N/A
N/A
Bcal Diagnostics Ltd (BDX) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at AUD0.09, down 5.56% from the previous close.
Over the past year, BDX has traded between a low of AUD0.05 and a high of AUD0.14. The stock has gained 1.2% over this period. It is currently 37.0% below its 52-week high.
Bcal Diagnostics Ltd has a market capitalization of $31.34M.
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Side-by-side comparison against top Healthcare peers.